Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers
Clinical trial NCT02955797 · COMPLETED
Trial details
- NCT number
- NCT02955797
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-24
- Primary completion
- 2017-10-26
- Enrollment
- 918
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.